Industry veteran recruited to develop new hearing enhancement devices, providing consumers with alternatives to conventional hearing aids
ROSEVILLE, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — via InvestorWire — InnerScope Hearing Technologies Inc. (OTC: INND) (“InnerScope” or the “Company”) today announces the appointment of Adnan Shennib as chief technology officer (“CTO”). Shennib brings over 30 years of experience in hearing innovations, having held leading roles with major hearing aid manufacturers, including ReSound®, developing the world’s first remotely controlled and most advanced hearing aid product on the market. In addition, Shennib founded InSound Medical and invented the Lyric® hearing device, the world’s smallest and only extended-wear hearing product currently on the market (acquired by Sonova-Phonak® in 2010 for $169 million).
More recently, Shennib founded iHEAR Medical Inc. (“iHEAR”), where he led the development of a groundbreaking online platform for direct-to-consumer (“DTC”) hearing markets. InnerScope recently announced the acquisition of iHEAR, which bolsters and solidifies the Company’s position as the leader in the emerging markets of DTC and over-the-counter (“OTC”) hearing products.
A Silicon Valley medical device entrepreneur, Shennib developed several landmark innovations, including the iHEARtest™, which is the only FDA-cleared home hearing test. Shennib’s innovations have received the Medical Device Excellence Award and have been featured by major media outlets, including CNN, The New York Times, The Dr. Oz Show, USA Today and Inc. Magazine. Shennib holds over 100 patents in hearing and medical devices, a B.S. in electrical and computer engineering from the University of California, Santa Barbara, and an M.S. in biomedical engineering from the University of Texas.
“We are pleased to welcome Adnan Shennib to develop new types of hearing devices with improved performance for tech-savvy consumers looking for alternatives to conventional hearing aids,” stated Matthew Moore, president and CEO of InnerScope. “We are proud to add Mr. Shennib to our team of seasoned experts as InnerScope’s CTO. Mr. Shennib is a pioneer in the hearing industry with a proven track record of developing patentable, groundbreaking discoveries in hearing technology. We are especially excited, with our recent acquisition of iHEAR, for Mr. Shennib to lead InnerScope’s new research and development team at our new FDA-registered manufacturing facility in San Leandro, California.”
“I am excited to join the InnerScope team to advance its mission of providing affordable advanced hearing solutions,” Shennib stated. “Our initial focus will be on developing proprietary products based on new understandings of consumer trends and behavior.”
Shennib will also serve as president of international operations to expand InnerScope’s partnerships with manufacturers, distributors and innovators worldwide.
About InnerScope Hearing Technologies, Inc. (OTC PINK: INND):
InnerScope is a leading manufacturer and distributor of FDA-registered hearing products and personal sound amplifier products (PSAPs), dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s products and business model break through persistent barriers that prevent access to effective hearing solutions. With its recent acquisition of iHEAR Medical, InnerScope is poised to expand its leadership in the direct-to-consumer hearing solutions market with innovative hearing products offered to consumers at a fraction of the cost of conventional hearing aids sold in hearing aid centers. For more information, please visit www.innd.com.
For the most up-to-date information about InnerScope Hearing Technologies (OTC: INND), please visit and follow our official Twitter account @inndstock page:
For information related to InnerScope Hearing Technologies’ latest hearing aids and related hearing products, please visit:
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, intended to be covered by the “safe harbor” created by those sections. Any statements that are not historical facts contained in this press release are also “forward-looking statements,” as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA). Such statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “intends,” “estimates” and other words of similar meaning. Such forward-looking statements are based on current expectations and involve known and unknown risks; a reliance on third parties for information, transactions or orders that may be canceled; and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing or maintain contractual relationships with vendors and customers, competition, general economic conditions, and other factors that are detailed in our periodic reports filed with the Securities and Exchange Commission (“SEC”). We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA, Securities Act and Securities Exchange Act.
InnerScope Hearing Technologies, Inc.
Investor Relations Agency Contact:
Skyline Corporate Communications Group, LLC
Lisa Gray, Senior Account Manager
One Rockefeller Plaza, 11th Floor
New York, NY 10020
Office: (646) 893-5835
The content is by GlobeNewswire. DKODING Media is not responsible for the content provided or any links related to this content. DKODING Media is not responsible for the correctness, topicality or the quality of the content.